The suppression of fibroblast growth factor 2/fibroblast growth factor 4-dependent tumour angiogenesis and growth by the anti-growth factor activity of dextran derivative (CMDB7)
1998

Inhibition of Tumor Growth and Angiogenesis by a Dextran Derivative

Sample size: 24 publication Evidence: high

Author Information

Author(s): R Bagheri-Yarmand, Y Kourbalil, C Mabilat, JF Morere, A Martin, H Lu, C Soria, J Jozefonvicze, M Crepin

Primary Institution: Laboratoire d'Oncologie Moleculaire Humaine, Université de Paris-Nord

Hypothesis

CMDB7 inhibits FGF-2/FGF-4-dependent tumor growth and angiogenesis.

Conclusion

CMDB7 is an effective inhibitor of tumor growth and angiogenesis in vivo.

Supporting Evidence

  • CMDB7 treatment suppressed tumor take and growth by about 50% and 80%, respectively.
  • Immunohistochemical analysis showed a significant decrease in endothelial density in treated tumors.
  • CMDB7 inhibited the mitogenic activities of conditioned media from breast cancer cell lines.

Takeaway

A special substance called CMDB7 helps stop tumors from growing by blocking the blood supply they need.

Methodology

The study involved in vitro assays on cell lines and in vivo experiments using nude mice to assess the effects of CMDB7 on tumor growth and angiogenesis.

Limitations

The study primarily focused on specific cell lines and may not fully represent all breast cancer types.

Participant Demographics

Swiss nude male athymic mice were used for in vivo experiments.

Statistical Information

P-Value

p<0.00001

Confidence Interval

95%

Statistical Significance

p<0.00001

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication